Results 61 to 70 of about 6,386 (141)

Treatment of clinically resistant cytomegalovirus retinitis in AIDS patients: Combination of intravenous ganciclovir and intravitreal foscarnet

, 1995
The treatment of clinically resistant cytomegalovirus retinitis in AIDS patients requires a combination of foscarnet and ganciclovir, but the poor clinical condition of some patients may weigh against this intravenous regimen.
V. Ciapparoni, Massimo Accorinti, V. Vullo, M. Accorinti, PIVETTI, Paola, P. Pivetti-Pezzi   +5 more
core   +1 more source

Recombinant Phenotyping of Cytomegalovirus UL54 Mutations That Emerged during Cell Passages in the Presence of either Ganciclovir or Foscarnet

, 2011
Selection of human cytomegalovirus variants in the presence of ganciclovir or foscarnet led to 18 DNA polymerase mutations, 14 of which had not been previously studied.
Nathalie Goyette, Sheng-Xiang Lin, Arezki Azzi, Christian Gilbert, Guy Boivin   +4 more
core   +1 more source

Pharmacokinetics of concomitantly administered foscarnet and zidovudine for treatment of human immunodeficiency virus infection (AIDS Clinical Trials Group protocol 053).

, 1992
Foscarnet and zidovudine (ZDV) pharmacokinetic parameters were not altered in five patients receiving 14 days of concomitant therapy. Foscarnet clearance in plasma averaged (+/- standard deviation) 0.16 +/- 0.03 and 0.13 +/- 0.05 liter/h/kg of body ...
Jacobson, M A, Raasch, R, van der Horst, C, Aweeka, F T, Gambertoglio, J G   +4 more
core   +1 more source

Treatment of cytomegalovirus esophagitis in patients with acquired immune deficiency syndrome: A randomized controlled study of foscarnet Versus ganciclovir

, 1998
Objective: Although several uncontrolled studies have shown that the response rate to ganciclovir and foscarnet for all forms of cytomegalovirus (CMV) infection in immunocompromised patients is almost similar, to date, no controlled clinical trial has ...
Moroni M., Ciammarughi R., Betri E., Cadrobbi P., D'Arminio A., Viale P., Coppola R., Cecchetto A., Castelli F., Vago L., Saresini A., Carniato S., Coen M., Trespi G., Cestari R., Antinori S., Ortona L., Ravetto F., Gerna G., Casadei G. P., Malaguti E., Gavazzeni G., Quercia G., Gianotti N., Lazzarin A., Rocca F., Girola M., Porro G. B., Gritti F., Bellomi A., Fanti L., Parente F., Antinori P., Carazzina G., Bodini P., Alberici F., Caprini A., Milazzo F., Crivellaro P., Vecchio P., Carnevale G., Villanacci V., Missale F., Cargnel A., Costanzi G., Tittobello A., Fiocca R., Parma A., Suter F., Cardelli A., Cantaboni A., Carosi G. P., Fasan A., Grogolato P., Scalzini F.   +54 more
core   +1 more source

Phase I-II Trial of Foscarnet for Prevention of Cytomegalovirus Infection in Autologous and Allogeneic Marrow Transplant Recipients

, 2017
The safety and efficacy of foscarnet for prevention of cytomegalovirus (CMV) infection was evaluated in 19 CMV-seropositive bone marrow transplant (BMT) recipients.
Reusser, Pierre, Lilleby, Kathy, Gambertoglio, John G., Meyers, Joel D.   +3 more
core  

Intravitreal foscarnet is an effective adjunct after systemic therapy failure in pediatric antiviral-resistant cytomegalovirus retinitis. [PDF]

J Int Med Res
Amiri I, Shah P, Soleimani M, Zhang AY.
europepmc   +1 more source

Case report: Maribavir as salvage therapy for multidrug-resistant CMV DNAemia in a non-transplant patient with ocular cicatricial pemphigoid. [PDF]

IDCases
Vaidyanathan BR, Balaji A.
europepmc   +1 more source

Maribavir for cytomegalovirus retinitis: A case series and review of the literature. [PDF]

AJO Int
Shughoury A, Emami S, Kaisari E, Kharouba R, Thomas AS, Goldstein DA, Janetos TM.   +6 more
europepmc   +1 more source

Evaluation of Cytomegalovirus Treatment in Transplant Patients Before and During the Foscarnet Nationwide Shortage

, 2012
Class of 2012 AbstractSpecific Aims: To compare and evaluate the therapies prescribed, the incidence of adverse drug events, and the time to clinical cure in transplant patients with a cytomegalovirus (CMV) infection at an academic medical center before ...
Leadbetter, Maggie, Hattrup, Allison, Matthias, Kathryn, Doehnert, Deborah, Yost, Sarah   +4 more
core  

Cytomegalovirus reactivation prevention and treatment post-hematopoietic stem cell transplantation: a Delphi study in four Gulf cooperation council countries. [PDF]

BMC Infect Dis
Prats JAGG, Farsi KA, Al-Khabori M, Al-Saadawi N, Alshemmari SH, Cherif H, Ibrahim D, Kaloyannidis P, Swaka RLSW.   +8 more
europepmc   +1 more source